Meeting people with diabetes is always so inspirational. Sometimes I can barely keep my head straight with three children and a career. But, people living with diabetes, not only have that, they also have diabetes that they have to think about 24/7. One theme I hear over and over is how exercise really helps to stay healthy both physically and emotionally. Today, I’d like to introduce you to MiniMed Ambassador, Vince, who was one of six people living with diabetes selected by Medtronic to be a Global Champion. He’s taken his diabetes diagnosis and used it to be a role model for many in the community!
I often compare living with type 1 diabetes to constantly being on a roller coaster. Even as I approach my thirteenth diaversary this winter, I still have my moments when I feel I don’t have control. In looking back at the past thirteen years, it is easy for me to recognize the single biggest struggle I have faced while living with T1D—acceptance. Acceptance of T1D, acceptance of not always being in control, and acceptance of the fact treatment alone will not keep me healthy.
Those early moments after diagnosis can easily be considered the darkest time period of my life. Immediately after my diagnosis was confirmed, I felt empty, alone, and in despair. In my mind, my life was essentially over. These feelings carried with me for some time as I utilized various methods of treatment to gain better control. During my darkest days, I was afraid to ask for help. I kept to myself and avoided support groups at all costs.
When my son was born five years ago, I recognized that the roller coaster of T1D continued to build momentum for an unhealthy life. I had been gaining weight and realized I needed to do more to stay healthy. It was at that time I decided regardless of the treatment plan, I controlled my path moving forward. So, I decided I was going to run!
Changing My Attitude
With the updated technology also came a developing passion for running. Starting the journey was not easy. I wasn’t able to make it to the end of my street (and I live only two houses from the end of the block). I was determined to not give up and slowly but surely, my newfound routine did get easier. Over the past five years training has been a continuous effort and an ongoing process. I started small and set short term goals. When I met a goal, I set my sights on something bigger. In just a short timeframe, I have transitioned from many 5k races to build distances of 10k, 15k, 10 miles, half marathon, triathlon, and a full marathon. I would not have been able to work my way up the racing ladder without the support from my Medtronic products. Utilizing technology like the MiniMed 530G system and Threshold Suspend was a huge factor in making such progress. Moving on to the MiniMed 630G system and now the MiniMed 670G system has made management during race season so much more consistent. Having my big brother on my hip keeps me confident in my management while exercising.
Through my running journey and improved control, I learned a great deal about myself, perseverance, and the understanding that I am able to live a healthy life with T1D. As an athlete living with type 1, I am determined more than ever to spread the message of promise and hope throughout the diabetes community. There are only bright skies with the ability to continuously adapt to life with type 1. I know now that it’s OK to ask for help, seek advice, and lean on others for support.
Becoming a Global Champion
Back in April I applied to become a Medtronic Global Champion. This program recognizes global athletes who face health challenges and, with the support of a medical device, live an active and fulfilling life through running. This coming weekend, I am proud to head to Minnesota and run in the Twin Cities Ten Miler as one of six people from 5 countries being recognized for not allowing diabetes to stop the run. In the days ahead, it is my goal to spread my story of hope to all who live with diabetes that we can continue to improve our overall quality of life. Germany Kent sums it up best. “If you’re struggling today, remember that life is worth living and believe that the best is yet to come. Remember that you are loved, you matter, and never forget that there is always hope.”
IMPORTANT SAFETY INFORMATION
CareLink™ Therapy Management Software for Diabetes is intended to be used together with advice from a healthcare professional familiar with the diagnosis and treatment of diabetes. Do not make any changes to treatment without talking to a healthcare professional first. For more information, please visit www.medtronicdiabetes.com/about/safety.html.
The Medtronic MiniMed 670G system requires a prescription and is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of Type 1 diabetes mellitus in persons, fourteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 670G System includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values.
The Guardian Sensor (3) is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a finger stick may be required. All therapy adjustments should be based on measurements obtained using a home glucose monitor and not on values provided by the Guardian Sensor (3).
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Do not use the serter on products other than the Enlite sensor or Guardian Sensor (3). Medtronic cannot guarantee the safety or efficacy of this product if used with other products. The reservoir is contraindicated for the infusion of blood or blood products. Infusion sets are indicated for subcutaneous use only and not for intravenous (IV) infusion or the infusion of blood or blood products. Insulin pump therapy is not recommended for those who are unwilling to perform at least four blood glucose tests per day. As insulin pumps use rapid acting insulin only, BG testing is required to help identify rapid glycemic deterioration due to insulin infusion occlusion, infusion site problems, insulin stability issues, user error, or a combination of these. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional.
The safety of the 670G system has not been studied in people with impaired kidney function. Please let your healthcare professional know if you have kidney disease so you and your healthcare professional can determine if the potential benefits of using the system outweigh the risks. The safety of the 670G system has not been studied in pregnant women, people with type 2 diabetes, or in people using other anti-hyperglycemic therapies apart from insulin. Please let your healthcare professional know if any of these conditions apply to you so you and your healthcare professional can determine if the potential benefits of using the system outweigh the risks.
For complete safety information, please consult the appropriate User Guide.
, type 1 diabetes